focus -WSS

focus

author：focus 2025-09-30 14:09:14 - browse：7882

Monica Bertagnolli -- Health Policy coverage from STAT — Monica Bertagnolli, the nominee to lead the National Institutes of Health Jeff Chiu/AP

Monica Bertagnolli, President Biden’s nominee to lead the National Institutes of Health, spent her confirmation hearing Wednesday stuck in the middle of Republicans’ and Democrats’ bickering over her agency’s role in high drug costs, ultimately refusing to commit to either party’s approach.

Bertagnolli similarly walked a line on government funding for gender-affirming care research and other hotly politicized health care issues, though she did stress that transgender youth are some of the country’s most vulnerable people.

The long-awaited hearing came months after Committee Chairman Bernie Sanders (I-Vt.) pledged to stall her confirmation process until Biden did more to address high drug prices, like an assurance that the NIH would insert reasonable pricing requirements into deals with commercial drugmakers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Intellia reports positive results for its CRISPR

WSS

ASCO: AstraZeneca says CAR

Ionis drug prevents swelling attacks due to hereditary angioedema

Ionis drug prevents swelling attacks due to hereditary angioedema

BMI, flaws aside, is found to be useful estimate of body fat in youth

Hubble vs. James Webb telescope images: See the difference

The Pandemic Treaty must support building strong health systems

hotspot

focus

focus

United colonoscopy coverage change 'may cost lives,' doctors say

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Duchenne breakthrough therapy leaves behind pioneering families

Letters to First Opinion on caregivers, digital health, and more

The cancer drug shortage isn’t new — and neither are the solutions

The biotech scorecard for Q3: 15 stock

Novavax promises a turnaround & Lilly roils the obesity market

Fatty liver disease was alleviated by Lilly’s ‘triple

At least 13 dead in Texas as scorching temps continue

Drug cartel violence flares in western Mexico after vigilante leader's killing

knowledge

Use doctors trained outside the U.S. to ease the physician shortage

A letter from the executive editor: The 2023 STATUS List

Vertex cell therapy lets patients with type 1 diabetes stop insulin

'Screen and refer' systems are hurting patients

Shifting the focus from loneliness to social health

ASCO: AstraZeneca says CAR

knowledge

Wikipedia

entertainment

entertainment